Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Journal of Korean Medical Science ; : 1650-1656, 2013.
Article Dans Anglais | WPRIM | ID: wpr-148462

Résumé

Congenital adrenal insufficiency is caused by specific genetic mutations. Early suspicion and definite diagnosis are crucial because the disease can precipitate a life-threatening hypovolemic shock without prompt treatment. This study was designed to understand the clinical manifestations including growth patterns and to find the usefulness of ACTH stimulation test. Sixteen patients with confirmed genotyping were subdivided into three groups according to the genetic study results: congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH, n=11), congenital lipoid adrenal hyperplasia (n=3) and X-linked adrenal hypoplasia congenita (n=2). Bone age advancement was prominent in patients with CAH especially after 60 months of chronologic age (n=6, 67%). They were diagnosed in older ages in group with bone age advancement (P<0.05). Comorbid conditions such as obesity, mental retardation, and central precocious puberty were also prominent in this group. In conclusion, this study showed the importance of understanding the clinical symptoms as well as genetic analysis for early diagnosis and management of congenital adrenal insufficiency. ACTH stimulation test played an important role to support the diagnosis and serum 17-hydroxyprogesterone levels were significantly elevated in all of the CAH patients. The test will be important for monitoring growth and puberty during follow up of patients with congenital adrenal insufficiency.


Sujets)
Adolescent , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , 17alpha-Hydroxyprogestérone/sang , Troubles du développement sexuel de sujets 46, XY/traitement médicamenteux , Hyperplasie congénitale des surrénales/traitement médicamenteux , Insuffisance surrénale/congénital , Hormone corticotrope/métabolisme , Développement osseux/génétique , Récepteur nucléaire orphelin DAX-1/génétique , Maladies génétiques liées au chromosome X/traitement médicamenteux , Génotype , Glucocorticoïdes/usage thérapeutique , Déficience intellectuelle/complications , Minéralocorticoïdes/usage thérapeutique , Obésité/complications , Phosphoprotéines/génétique , Puberté précoce/complications , Études rétrospectives , Steroid 21-hydroxylase/génétique
SÉLECTION CITATIONS
Détails de la recherche